|
業務類別
|
Drug Manufacturers - Specialty & Generic |
|
業務概覽
|
Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries. |
| 公司地址
| 100 Summer Street, Suite 2300, Boston, MA, USA, 02110 |
| 電話號碼
| +1 617 621-7722 |
| 傳真號碼
| +1 617 494-0480 |
| 公司網頁
| https://www.ironwoodpharma.com |
| 員工數量
| 253 |
| Ms. Tammi L. Gaskins |
Senior Vice President and Chief Commercial Officer |
-- |
28/04/2025 |
| Mr. Thomas A. McCourt |
Director, President and Chief Executive Officer |
美元 867.57K |
26/02/2026 |
| Mr. Gregory S. Martini |
Senior Vice President and Chief Financial Officer |
-- |
26/02/2026 |
| Dr. Michael Shetzline, M.D.,PhD |
Senior Vice President, Chief Medical Officer and Head of Research and Drug Development |
美元 557.57K |
28/04/2025 |
| Mr. John Minardo |
Senior Vice President, Chief Legal Officer and Secretary |
美元 531.75K |
28/04/2025 |
| Mr. Ronald Silver, C.P.A. |
Principal Accounting Officer, Senior Vice President and Corporate Controller |
-- |
26/02/2026 |
|
|
| Dr. Alexander J. Denner, PhD |
Independent Director |
26/02/2026 |
| Mr. Jay P. Shepard |
Independent Director |
26/02/2026 |
| Dr. Mark G. Currie,PhD |
Independent Director |
26/02/2026 |
| Mr. Thomas A. McCourt |
Director, President and Chief Executive Officer |
26/02/2026 |
| Ms. Julie H. McHugh |
Chairman of the Board |
26/02/2026 |
| Ms. Catherine Moukheibir |
Independent Director |
26/02/2026 |
| Mr. Jon R. Duane |
Independent Director |
26/02/2026 |
| Ms. Marla L. Kessler |
Independent Director |
26/02/2026 |
|
|
|
|
